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Objectives. This study sought to evaluate whether myocardial
viability, as assessed by magnetic resonance imaging (MRI),
reliably predicts postrevascularization left ventricular (LV) recov-
ery.
Background. Compared with positron emission tomographic
findings, MRI has proved to be a reliable technique for the
identification of residual myocardial viability. However, the pre-
dictive accuracy of MRI-assessed preserved end-diastolic wall
thickness (DWT) and dobutamine-induced systolic wall thicken-
ing (SWT) for LV functional recovery has not yet been evaluated.
Methods. Rest and low dose dobutamine MRI was performed in
43 patients with a chronic infarct (>4 months since ischemic
event) and LV dysfunction who had undergone revascularization
of the infarct-related vessel. On the basis of segmental evaluation
of corresponding short-axis tomograms, infarct regions were
graded viable by MRI if 1) DWT was >25.5 mm, and 2)
dobutamine-induced SWT was >22 mm in >250% of dysfunctional
segments related to the infarct region. Functional recovery was
defined as SWT >22 mm in >250% of infarct-related segments at
rest 4 to 6 months after successful revascularization.
Results. Recovery of regional SWT could be observed in 27
(63%) of 43 patients. Comparison MRI grading before and after
revascularization indicated that dobutamine-induced SWT was a
better predictor of LV functional recovery (sensitivity 89%, spec-
ificity 94%) than was preserved DWT (sensitivity 92%, specificity
56%). Segments that remained akinetic after revascularization
had significantly lower DWT (6.0 6 3.1 mm [n 5 219] vs. 9.8 6
2.6 mm [n 5 188], p < 0.001) than those with improved SWT. Left
ventricular ejection fraction increased significantly in patients
with dobutamine-induced SWT than in those with no contractile
reserve (14 6 9% vs. 3 6 9%, p < 0.0002), and the magnitude of
this increase was correlated with the number of dobutamine-
responsive segments per infarct region (r 5 0.68, p < 0.0001).
Conclusions. Quantitative assessment of dobutamine-induced
SWT in chronic infarcts by MRI is a highly accurate predictor of
LV functional recovery, and the presence of significantly reduced
DWT reliably indicates irreversible myocardial damage. There-
fore, dobutamine stress testing for the assessment of myocardial
viability can be restricted to patients with preserved DWT.
(J Am Coll Cardiol 1998;31:1040–8)
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Because patients with impaired left ventricular (LV) function
benefit most from revascularization (1,2), the reliable differ-
entiation of irreversibly damaged scar tissue and potentially
salvageable viable myocardium is of major clinical importance
(3,4). Compared with established scintigraphic (5,6) or sono-
graphic imaging techniques, which depict different variables of
myocardial viability on a qualitative or semiquantitative basis
(7–9), magnetic resonance imaging (MRI) seems to be ideally
suited to assess functional and morphologic variables of myo-
cardial viability quantitatively (10–14). In previous studies,
MRI-assessed dobutamine-induced systolic wall thickening
(SWT) proved to be a reliable indicator of myocardial viability,
as defined by positron emission tomographic (PET) findings
(15,16). In contrast, the value of preserved end-diastolic wall
thickness (DWT) as an indicator of persistent myocardial
viability in chronically dysfunctional myocardium is still con-
troversial (16,17), because some investigators found residual
metabolic activity in the form of glycolysis by fluorine-18
fluorodeoxyglucose PET in myocardial regions with reduced
DWT and absent SWT (16).
Therefore, the aim of the present study was to compare the
predictive value of quantitatively assessed dobutamine-
induced SWT and preserved DWT for the recovery of LV wall
thickening (SWT), as assessed by MRI in the clinical setting of
1) a chronically akinetic or dyskinetic infarct region, with 2)
severe stenosis of the infarct-related coronary artery ($80%
diameter reduction); and 3) angiographically documented suc-
cessful revascularization after 4 to 6 months.
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Methods
Study patients. We prospectively studied 122 consecutive
patients with chronic coronary artery disease between June
1993 and December 1996 who were referred to our hospital for
the assessment of residual myocardial viability. Only patients
with a documented history of previous myocardial infarction
(MI) ($4 months since the ischemic event) and regional LV
akinesia or dyskinesia by left ventriculography were included in
the present study. Patients were excluded if they had unstable
angina, congestive heart failure, atrial fibrillation or a history
of sustained ventricular tachycardia. A subset of 43 patients (40
men, 3 women; age 32 to 76 years old, mean [6SD] age 58 6
9), who formed the study group had a successfully grafted (n 5
21) or interventionally treated (n 5 22) infarct-related vessel
documented by follow-up coronary angiography 4 to 6 months
after revascularization (Table 1). Of these 43 patients, 25 had
an anterior and 18 an inferior MI (mean infarct age 17 6 28
months). Thirteen patients had one-vessel, 16 had two-vessel,
and 14 had three-vessel coronary artery disease. Mean LV
ejection fraction (LVEF) was 42 6 10% before and 51 6 15%
after revascularization. The study was approved by the hospi-
tal’s human rights committee (institutional review board), and
written informed consent was obtained from each patient.
All patients underwent coronary and LV angiography and
dobutamine MRI studies within 10 days, without intervening
cardiac events before revascularization, and follow-up coro-
nary and LV angiography and rest MRI studies 4 to 6 months
after revascularization. Beta-adrenergic blocking agents were
withdrawn 48 h before the test. All patients received a long-
acting nitrate (Isoket Retard 120) before dobutamine MRI
studies to allow for constant coronary artery vasodilation.
Coronary angiography. Regional LV wall motion was vi-
sually evaluated from the left ventriculogram and graded as
normokinetic, hypokinetic, akinetic or dyskinetic by two inde-
pendent, experienced observers (F.M.B., C.A.S.). In case of
disagreement (n 5 3), a third observer (U.S.) reviewed the
study, and the majority judgment was binding. Only patients
with regional akinesia or dyskinesia at least 4 months after the
ischemic event were included in the study. LVEF was calcu-
lated by the area–length method, and multiple views of each
coronary artery were obtained (DCI, Philips, Eindhoven, The
Netherlands) before and after revascularization. Coronary
artery or bypass graft narrowing was assessed as percent
diameter stenosis by means of electronic calipers. Patients with
.70% diameter restenosis of the infarct-related vessel or
.70% diameter stenosis of the infarct-related bypass graft at
follow-up angiography were excluded from the study because
recurrent hibernation could not be ruled out.
Rest MRI. Magnetic resonance images were obtained by
using a 1.5-tesla superconducting magnet (Philips Gyroscan
S15 and ACS NT). Multislice, sagittal and transaxial electro-
cardiographic (ECG) gated spin-echo sequences were ac-
quired to define the cardiac axes. The entire left ventricle
was covered by short-axis tomograms using a conventional
gradient echo sequence and a faster breathhold turbo field
gradient echo technique since February 1996 (18). The flow-
compensated conventional gradient echo sequence used flip
angles of 30° and gradient-refocused echoes with an echo time
(TE) of 12 ms and a repetition time (TR) of 28 ms (19). The
field of view was 280 mm, and measurements were repeated
four times to improve the signal to noise ratio. The turbo field
gradient echo sequence used a flip angle of 30° and gradient-
refocused echoes with a TE of 8 ms and a TR of 4 ms. The
acquisition matrix was 128 3 256 interpolated to 256 3 256 for
display purposes. The acquisition pixel size was 2.5 3 1.25 mm.
Dobutamine MRI. Without removing the patient from the
magnet, dobutamine (Dobutrex) was administered intrave-
nously under continuous ECG monitoring and blood pressure
recording (Boso Oscillomat) every 2 min. Using a digital
perfusion pump (Secura FT, B. Braun, Melsungen AG), a dose
of 10 mg/kg body weight per min was infused into a peripheral
vein beginning 5 min before and ending after the MRI
acquisition. Total imaging time for rest and dobutamine MRI
studies ranged from 20 to 30 min for the breathhold turbo field
gradient echo technique and from 60 to 80 min for the
conventional gradient echo technique, and was also deter-
mined by the patient’s heart rate and the number of slices
needed to cover the entire left ventricle.
MRI analysis. Each MRI study acquired at rest and during
dobutamine infusion and after revascularization was previewed
in a cinematic mode from base to apex to define end-diastolic
and end-systolic phase images, with the smallest or largest LV
endocardial area during the cardiac cycle. End-diastolic and
end-systolic endocardial and epicardial contours were elec-
tronically traced and manually corrected when appropriate.
The center of mass was determined by a modified image
processing software, allowing division of each short-axis tomo-
gram into eight segments by equally spaced radii of 45° (Fig. 1)
emanating from the endocardial center of mass. Segmental
DWT and SWT was calculated as the mean value of serial
measurements (10 per segment) of distances (chords) between
endocardial and epicardial contours using a modified center-
line method on an Apple Power PC platform. SWT at rest
before and after revascularization was calculated by subtract-
ing mean DWT from mean SWT (16). The same evaluation
procedure was performed for the corresponding dobutamine
and postrevascularization MRI studies. Dobutamine-induced
Abbreviations and Acronyms
DWT 5 end-diastolic wall thickness
ECG 5 electrocardiogram, electrocardiographic
LV 5 left ventricular
LVEF 5 left ventricular ejection fraction
MI 5 myocardial infarction
MRI 5 magnetic resonance imaging
PET 5 positron emission tomography (tomographic)
SWT 5 systolic wall thickness (thickening)
TE 5 echo time
TR 5 repetition time
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contractile reserve was calculated as dobutamine-induced
SWT minus SWT at rest.
A segment was defined as viable if 1) SWT or dobutamine-
induced SWT was $2 mm; or 2) the mean DWT was $5.5 mm.
This threshold value was based on the mean DWT (10.5 6
2 mm) of a healthy control group (n 5 21) minus 2.5 SD (13).
The entire infarct region was graded viable if $50% of
segments fulfilled morphologic or functional MRI viability
Table 1. Clinical, Left Ventriculographic, Coronary Angiographic and Prerevascularization and Postrevascularization Magnetic Resonance
Imaging Findings
Pt No./
Gender
Age
(yr)
Infarct
Age (mo)
Infarct
Region
Coronary Angiographic and Revascularization Data
Infarct Region-Related Grading of Residual Viability
Revasc
Proc
Stenoses (% DR)
LVEF (%):
Pre/Post
Rest MRI
(DWT $5 mm)
Dobutamine MRI
(dob-SWT $2 mm)
Post-MRI
(rest SWT $2 mm)LAD LCx RCA CC
1/M 53 6 AMI BCR 100 0 0 RCA 59/69 Viable Viable LV recovery
2/M 50 7 AMI CABG 80 100 0 — 56/50 Scar Scar No recovery
3/M 67 8 IMI CABG 70 95 100 LAD 35/55 Viable Viable LV recovery
4/M 62 6 IMI CABG 80 60 100 LCx 54/70 Viable Viable LV recovery
5/F 55 4 AMI CABG 80 0 85 — 44/46 Scar Scar No recovery
6/M 60 4 IMI CABG 70 90 90 — 49/65 Viable Viable LV recovery
7/M 61 13 AMI CABG 100 60 95 — 47/45 Scar Scar No recovery
8/M 63 5 IMI PTCA 0 0 95 — 51/57 Viable Viable LV recovery
9/M 54 8 AMI CABG 80 0 95 — 24/22 Scar Scar No recovery
10/M 53 4 IMI PTCA 0 0 95 — 55/63 Viable Viable LV recovery
11/M 64 5 AMI PTCA 90 50 0 — 39/42 Viable Viable LV recovery
12/M 57 6 AMI CABG 90 50 80 — 29/20 Scar Scar No recovery
13/M 60 5 AMI PTCA 95 0 100 — 49/60 Viable Viable LV recovery
14/M 63 4 IMI PTCA 0 0 80 — 48/42 Scar Scar LV recovery
15/M 69 4 IMI CABG 70 0 100 — 49/64 Viable Scar LV recovery
16/M 64 6 AMI PTCA 95 0 0 — 45/63 Viable Viable LV recovery
17/M 65 15 IMI PTCA 0 0 90 — 55/81 Viable Scar LV recovery
18/F 55 4 AMI BCR 100 0 0 — 34/64 Viable Viable LV recovery
19/M 56 5 IMI PTCA 50 0 95 — 42/65 Viable Viable LV recovery
20/M 54 6 IMI BCR 0 100 100 — 45/46 Viable Viable LV recovery
21/M 47 120 IMI CABG 70 70 100 — 41/46 Viable Viable LV recovery
22/M 38 8 AMI PTCA 80 0 0 — 32/29 Scar Scar No recovery
23/M 46 4 AMI CABG 95 95 0 — 26/29 Viable Scar No recovery
24/M 58 11 IMI CABG 80 50 90 — 25/37 Viable Viable LV recovery
25/M 64 146 AMI CABG 95 70 95 — 39/30 Viable Scar No recovery
26/M 61 8 AMI CABG 100 50 100 — 38/59 Viable Viable LV recovery
27/M 70 24 AMI CABG 100 60 70 — 25/28 Scar Scar No recovery
28/M 32 5 AMI BCR 100 0 0 — 56/65 Viable Scar No recovery
29/F 72 8 AMI BCR 100 0 100 LCx 33/51 Scar Scar No recovery
30/M 61 5 IMI CABG 60 80 100 — 48/59 Scar Viable LV recovery
31/M 56 7 IMI PTCA 0 80 0 — 29/40 Viable Viable LV recovery
32/M 50 12 AMI CABG 100 0 60 — 59/60 Viable Viable LV recovery
33/M 67 14 AMI PTCA 90 0 0 — 20/43 Viable Viable LV recovery
34/M 51 36 AMI PTCA 95 0 0 45/71 Viable Viable LV recovery
35/M 42 9 IMI PTCA 0 0 90 — 47/60 Viable Viable LV recovery
36/M 64 36 IMI CABG 95 70 100 — 48/45 Viable Scar No recovery
37/M 67 30 AMI PTCA 90 50 100 — 46/65 Viable Viable LV recovery
38/M 55 13 IMI CABG 100 0 100 — 34/44 Scar Scar No recovery
39/M 55 5 IMI PTCA 0 90 95 — 37/42 Viable Viable No recovery
40/M 58 60 AMI PTCA 100 50 0 — 33/37 Viable Scar No recovery
41/M 69 10 AMI CABG 70 80 0 — 39/61 Viable Viable LV recovery
42/M 76 12 AMI CABG 100 50 95 LCx 37/39 Viable Scar No recovery
43/M 62 6 AMI BCR 100 60 0 — 49/70 Viable Viable LV recovery
AMI 5 acute myocardial infarction; BCR 5 balloon catheter revascularization; CABG 5 coronary artery bypass graft surgery; CC 5 collateral circulation; DR 5
coronary artery diameter reduction; dob-SWT 5 dobutamine-induced systolic wall thickening; DWT 5 diastolic wall thickness at rest; F 5 female; IMI 5 inferior
myocardial infarction; LAD 5 left anterior descending coronary artery; LCx 5 left circumflex coronary artery; LV 5 left ventricular; LVEF 5 left ventricular ejection
fraction; M 5 male; MRI 5 magnetic resonance imaging; Post 5 after revascularization; Pre 5 before revascularization; PTCA 5 percutaneous transluminal coronary
angioplasty; RCA 5 right coronary artery; Revasc Proc 5 revascularization procedure; SWT 5 systolic wall thickening. Boldface type indicates discrepant findings of
rest MRI, dobutamine MRI and postrevascularization MRI.
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criteria. Improvement of LV function after revascularization
was defined as SWT $2 mm. Functional recovery of the infarct
region after successful revascularization was defined as SWT
$2 mm in $50% of the prerevascularization dysfunctional
infarct region-related segments.
Statistical analysis. Results are expressed as mean value 6
SD. Simple regression analysis was performed to assess corre-
lation of LVEF with the number of dobutamine-responsive
segments. Analysis of variance was performed to evaluate the
significance level of mean LVEF for different MRI viability
categories. Sensitivity, specificity and predictive accuracy of
DWT and dobutamine-induced SWT were calculated by ap-
plying standard formulas. The null hypothesis was rejected at
the 95% confidence level, with p ,0.05 significant.
Results
Patients. Of the 122 patients who initially underwent do-
butamine MRI, a subgroup of 43 had successful catheter-based
interventional therapy (n 5 22) or patent bypass grafts (n 5
21) (Table 1). These 43 patients had a total of 1,832 MRI
segments quantitatively evaluated with respect to DWT and
SWT at rest before revascularization, during low dose dobut-
amine stress (10 mg/kg per min) and 4 to 6 months after
successful revascularization. Of the 1,832 segments, 48 (2.6%)
were excluded because of inadequate image quality for quan-
titative wall thickening analysis, 1,353 had SWT $2 mm at rest,
and 431 were graded dysfunctional (SWT ,2 mm). Of these
431 segments, 407 could be assigned to successfully revascu-
larized infarct regions, whereas the other 24 segments be-
longed to nonrevascularized or unsuccessfully revascularized
regions. The present study focuses on analysis, before and after
revascularization, of the 407 chronically akinetic or dyskinetic
segments (Fig. 2) that could be related to 43 individual infarct
zones.
Segmental assessment of DWT and dobutamine-induced
SWT before revascularization. During low dose dobutamine
stress, 197 (48%) of 407 dysfunctional segments at baseline
conditions manifested significant SWT (Table 2). The remain-
ing 210 dysfunctional segments (52%) did not show functional
Figure 1. Segmental evaluation pattern for corresponding rest, dobut-
amine and postrevascularization MRI studies. Diagram illustrates the
position of adjacent short-axis tomograms encompassing the entire left
ventricle. Each short-axis tomogram from base to apex was divided
into eight segments by equally spaced radii of 45° emanating from the
endocardial center of mass (M). Segments were counted clockwise
beginning from the anterior junction (I) of the interventricular septum
and the right ventricular wall. The number of short-axis tomograms
needed to cover the left ventricle ranged from 6 to 12, with an average
number of eight slices.
Figure 2. Distribution of segmental grading
based on quantitative assessment of DWT,
dobutamine-induced SWT (Dobu-SWT) and
postrevascularization recovery of LV function.
seg. 5 segment.
Table 2. Comparison of Magnetic Resonance Imaging Findings
Based on Dobutamine-Induced Systolic Wall Thickening and End-
Diastolic Wall Thickness With Postrevascularization Recovery of
Systolic Wall Thickening
Dobutamine MRI (10 mg/kg per min)
(407 akinetic segments)
Rest MRI
(407 akinetic segments)
MRI
Post
Dobutamine-
Induced SWT
Total
Preserved
DWT
TotalViable Scar Viable Scar
Recovery 155 33 188 176 12 188
Scar 42 177 219 106 113 219
197 210 407 282 125 407
MRI Post 5 magnetic resonance imaging after successful revascularization;
other abbreviations as in Table 1.
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improvement during dobutamine infusion and were therefore
graded as scar. Preserved DWT as a variable of viability was
present in 282 (69%) of 407 dysfunctional segments at rest, and
125 segments (31%) were graded as scar based on diastolic
wall thinning (Table 2). Overall diagnostic agreement between
grading of viability based on DWT measurements and
dobutamine-induced SWT was 77% (314 of 407 segments).
Viability by preserved DWT was demonstrated in 193 (98%) of
197 segments with dobutamine-induced SWT, but also in 89
(42%) of 210 segments with persistent akinesia or dyskinesia
during low dose dobutamine stress (Fig. 2).
Patient-based assessment of DWT and dobutamine-
induced SWT before revascularization. Segmental evaluation
of dobutamine-induced SWT (i.e., at least 50% of dysfunc-
tional segments related to an infarct region must have a
positive response to dobutamine to grade the infarct region as
viable) and DWT (i.e., at least 50% of dysfunctional segments
related to an infarct region must have preserved DWT to grade
the infarct region as viable) was further used for a patient-
specific evaluation of individual infarct regions. On the basis of
these criteria, viable myocardium was identified by dobutamine-
induced SWT in 25 (58%) of 43 patients and by preserved
DWT in 32 (74%) of 43 patients. Overall diagnostic agreement
between patient-based grading of viability with respect to
DWT measurements and dobutamine-induced SWT was 79%
(34 of 43 patients).
Segmental assessment of SWT after successful revascular-
ization. Of 407 akinetic or dyskinetic segments, 188 (46%)
showed SWT $2 mm after successful revascularization, and
219 remained below this threshold. DWT in segments with
postrevascularization recovery was significantly higher (9.8 6
2.6 vs. 6.0 6 3.1 mm, p , 0.001) than that in segments
remaining akinetic despite adequate revascularization. Of the
188 segments with improved SWT after revascularization, 155
(82%) were graded as viable by MRI-assessed dobutamine-
induced SWT before revascularization. Of 219 segments with
persistent dysfunction despite successful revascularization, 42
(19%) were graded as viable by dobutamine-induced SWT
(Table 2). Improved LV function could be demonstrated in
176 (62%) of 282 segments with preserved DWT, but 106
segments (48%) with preserved DWT remained akinetic after
revascularization. Of 125 segments graded as scar based on
significant reduction of DWT, 12 (9.6%) recovered after
revascularization (Table 2). These 12 segments had a DWT
.5 mm, close below the threshold value of 5.5 mm.
Patient-based prediction of postrevascularization LV re-
covery according to functional and morphologic MRI viability
variables. Recovery of regional LV function based on the
measurement of SWT at rest ($2 mm in $50% of akinetic
segments) was observed in 27 (63%) of 43 successfully revas-
cularized infarct regions (Fig. 3). Three (11%) of 27 patients
with postrevascularization recovery of regional SWT were not
detected by MRI, and one (6%) of 16 patients did not show
improvement of SWT despite dobutamine-inducible contrac-
tile reserve (Table 3). The overall diagnostic agreement be-
tween MRI viability gradings based on dobutamine-induced
SWT and postrevascularization improvement of SWT was 91%
(39 of 43 infarct regions).
Preserved DWT was documented in 25 (92%) of 27 infarct
regions with functional recovery after revascularization and in
9 (56%) of 16 infarct regions with persistent akinesia (Table 3).
In 9 (82%) of 11 patients with persistent myocardial dysfunc-
tion after revascularization, DWT was significantly reduced
(Fig. 4). The overall diagnostic agreement between MRI
grading of viability based on preserved DWT and postrevas-
Figure 3. Rest MRI (left), dobutamine MRI (cen-
ter) and MRI after percutaneous transluminal coro-
nary angioplasty (Post-PTCA) (right) short-axis to-
mograms at end-diastole (top) and systole (bottom)
from a patient with an anterior MI and total occlu-
sion of the left anterior descending coronary artery.
The end-diastolic phase shows normal DWT at rest
(top left panel) and a lack of SWT of the septum and
the anteroseptal portion of the anterior wall (bottom
left panel, arrow). During dobutamine infusion (bot-
tom center panel), there was significant dobutamine-
induced SWT (4 mm in the septal region, arrow-
head), indicating viable tissue. Four months after
recanalization of the left anterior descending coro-
nary artery, there was normal rest SWT (bottom
right panel, arrowhead) of the anteroseptal region.
LV 5 left ventricle; RV 5 right ventricle.
Table 3. Infarct Region–Based Predictive Accuracy of Magnetic
Resonance Imaging–Assessed Dobutamine-Induced Systolic Wall
Thickening and Preserved End-Diastolic Wall Thickness for
Recovery of Regional Left Ventricular Function After Successful
Revascularization
Dob-SWT
($2 mm)
Preserved
DWT
($5.5 mm)
Sensitivity 89% (24/27) 92% (25/27)
Specificity 94% (15/16) 56% (9/16)
Pos predictive accuracy 96% (24/25) 78% (25/32)
Neg predictive accuracy 83% (15/18) 82% (9/11)
Diagnostic accuracy 91% (39/43) 79% (34/43)
Neg 5 negative; Pos 5 positive; other abbreviations as in Table 1.
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cularization improvement of SWT was 79% (34 of 43 infarct
regions).
Disagreement between functional and morphologic identi-
fication of myocardial viability by MRI occurred in nine
patients. The majority of eight patients had preserved DWT
but no significant dobutamine-induced SWT; one patient
presented with dobutamine-induced SWT despite diastolic
wall thinning. Of the eight patients with preserved DWT and a
lack of dobutamine-induced SWT in the dysfunctional infarct
zone, two showed improvement of SWT after successful revas-
cularization. The patient with dobutamine-induced SWT de-
spite diastolic wall thinning also had improved SWT of the
infarct region after revascularization.
Prediction of improved LVEF after revascularization by
dobutamine-induced SWT. Mean LVEF before revasculariza-
tion was not significantly different between patients with (43 6
10%, n 5 25) and those without (40 6 11%, n 5 18)
dobutamine-induced SWT in infarct-related segments. In con-
trast, LVEF increased significantly in patients with dobutamine-
induced SWT compared with those who were graded as having
predominantly scar tissue (14 6 9% vs. 3 6 10%, p , 0.0003),
and the magnitude of this increase was correlated with the
number of dobutamine-responsive segments assigned to an
individual infarct region (r 5 0.68, p , 0.0001) (Fig. 5). All
patients with four or more dobutamine-responsive dysfunc-
tional segments (n 5 29) had an increase in LVEF 4 to 6
months after revascularization. This increase from 42 6 10%
to 55 6 12% was significantly higher (p , 0.0001) than that in
patients with less than four dobutamine-responsive dysfunc-
tional segments who had an almost unchanged LVEF (42 6
11% to 43 6 18%). Table 1 shows the individual LVEFs before
and after revascularization.
Discussion
Assessment of residual myocardial viability in the setting of
dysfunctional myocardium due to significant coronary artery
disease is a key issue in making clinical decisions with respect
to revascularization procedures, because improvement of re-
gional systolic function can be achieved if successful revascu-
larization of viable myocardium is performed (20,21). Because
regional myocardial asynergy may arise from scar tissue or
akinetic but viable myocardium (22,23), the presence of re-
gional contractile abnormalities alone does not reliably in-
dicate the absence of potentially salvageable myocardium.
Previously, good correspondence between fluorine-18 fluoro-
deoxyglucose PET and dobutamine-induced SWT was re-
ported for the identification of dysfunctional but viable myo-
cardium (16). Moreover, based on pathologic-anatomic data,
the preservation of DWT as assessed by MRI in akinetic
myocardial regions was proposed to be a morphologic indica-
tor of viable myocardium (10,11,16,19). However, the predic-
tive value of MRI-assessed dobutamine-induced SWT with
respect to postrevascularization recovery of LV function has
not yet been examined. Therefore, the present study was
designed to extend previous observations of functional and
morphologic MRI viability variables by adding angiographic
information on functional recovery 4 to 6 months after suc-
cessful revascularization and the state of the vessels supplying
the dysfunctional infarct region. To allow for optimal prerevas-
cularization and postrevascularization comparison of regional
LV function, MRI-assessed SWT was used as the standard to
Figure 4. Rest MRI (left), dobutamine MRI (cen-
ter) and MRI after coronary artery bypass graft
surgery (Post-CABG) (right) short-axis tomograms
at end-diastole (top) and systole (bottom) from a
patient with an anterior MI and three-vessel disease.
At rest (top left panel), the DWT of the anteroseptal
wall appears significantly reduced (arrowheads), and
the entire region shows a lack of SWT. During
dobutamine infusion there was no measurable con-
tractile reserve in the anteroseptal region (bottom
center panel), indicating scar tissue. Six months after
successful revascularization (Post-CABG) of the left
anterior descending coronary artery, there was per-
sistence of end-diastolic wall thinning (top right
panel, arrowheads) and no improvement of SWT at
rest (bottom right panel). Abbreviations as in Figure 3.
Figure 5. Correlation of dobutamine-responsive dysfunctional seg-
ments with the change in LVEF after revascularization. Delta-
LVEF 5 magnitude of change in LVEF before and after revascular-
ization.
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evaluate improvement of LV function after revascularization.
The results indicate that quantitative assessment of dobutamine-
induced SWT is a highly reliable and clinically feasible indica-
tor of postrevascularization improvement of regional LV func-
tion. Moreover, the number of dysfunctional segments with
dobutamine-induced SWT provides a rough estimate of the
potential increase in LVEF after revascularization. Evaluation
of preserved DWT alone resulted in overestimation of the
amount of viable myocardium compared with functional im-
provement after successful revascularization. However, the
presence of diastolic wall thinning excludes a clinically relevant
amount of viable myocardial tissue, suggesting that patients
with chronic MI and significant wall thinning of the dysfunc-
tional myocardial region do not need to be exposed to addi-
tional dobutamine-stress tests.
MRI variables for myocardial viability. Two definitions of
myocardial viability were applied in the present study. The first
definition was based on the mean DWT 22.5 SD of a healthy
control group. With this definition of DWT, the segmental
cutoff values (5.5 mm) are in good agreement with measure-
ments from autopsied hearts that showed that chronic trans-
mural scar measures ,6 mm in thickness (24). Moreover,
intraoperative biopsies from asynergic LV regions showed
,10% muscle loss if regional function was improved postop-
eratively (viable myocardium), whereas muscle loss was .50%
in regions without recovery (scar tissue) (25).
A situation of chronic contractile dysfunction in hypoper-
fused but viable myocardium that normalizes on reperfusion
has been clinically defined as hibernation (22). The improve-
ment of LV wall motion in regions of hibernating myocardium
during inotropic stimulation was reported to be indicative of
improved LV function after revascularization (26–28). There-
fore, the second MRI definition of viability was based on the
measurement of dobutamine-induced SWT ($2 mm) in ba-
sally akinetic segments that proved to be a reliable functional
indicator of myocardial viability, even with qualitative analysis
usually performed in echocardiographic studies (7,8,29).
Prediction of LV functional recovery based on dobutamine-
induced SWT. Viability based on dobutamine-induced SWT
was diagnosed in 25 (58%) of 43 patients with chronic MI and
severe wall motion abnormalities. Comparison of viability
prediction by dobutamine-induced SWT with the postrevascu-
larization outcome of infarct region-related SWT yielded an
agreement of 91% (39 of 43 infarct regions). On segmental
evaluation, a positive response to dobutamine as assessed by
MRI correctly identified 332 (82%) of 407 segments with
respect to functional improvement after revascularization, and
the positive predictive accuracy was 79%. To our knowledge,
no other study has used dobutamine MRI to address the
question of viability with regard to LV recovery after successful
revascularization in patients with chronic MI. However, a
segmental approach to the prediction of LV functional im-
provement based on the evaluation of dobutamine-induced
contractile reserve in patients with chronic MI, as in the
present study, was used in several previous echocardiographic
studies. A study using dobutamine echocardiography before
coronary artery bypass graft surgery and follow-up echocardi-
ography 3 months after revascularization in 33 patients with
chronic coronary artery disease was published by LaCanna et
al. (30). The sensitivity of dobutamine echocardiography for
identifying functional recovery on a segmental basis was 92%;
specificity was 75%; and diagnostic accuracy was 84%. Cigar-
roa et al. (31) reported that 24 (49%) of 49 patients with
chronic MI showed dobutamine-induced contractile reserve. In
25 patients who underwent revascularization, 9 (82%) of 11
with contractile reserve had improved SWT after revascular-
ization, and 12 (86%) of 14 patients without contractile reserve
had no improved SWT. Perrone-Filardi et al. (32) reported a
detection rate of 88% for LV recovery of dysfunctional regions
by dobutamine echocardiography, with a positive predictive
accuracy of 91%. The overall sensitivities of echocardiographic
studies for the prediction of LV functional recovery after
revascularization (range 86% to 92%) are in good agreement
with the MRI findings (sensitivity 89%) of the present study.
However, the specificity (94%) of quantitatively assessed
dobutamine-induced contraction reserve by MRI for the im-
provement of LV function is better than the specificity re-
ported in echocardiographic studies (range 75% to 86%). The
higher specificity of MRI-assessed dobutamine-induced SWT
with respect to improvement of LV function after revascular-
ization may be due to the quantitative MRI approach, in
contrast to the qualitative visual analysis usually achieved in
stress echocardiographic studies. Measurement of dobutamine-
induced SWT is likely to eliminate visual effects of wall motion,
especially in the transition zone between normal and scar
tissue, which can mimic contractile reserve even when a
thorough visual analysis is done.
Detection of viable myocardium by preserved DWT. Com-
parison of infarct region-related DWT and postrevasculariza-
tion recovery of SWT yielded corresponding gradings in 34
(79%) of 43 basally akinetic or dyskinetic infarct regions. The
sensitivity was 92%, with a significantly lower specificity of 56%
(i.e., of 16 infarct regions without postrevascularization recov-
ery of regional LV function, seven had preserved DWT in
.50% of segments encompassing the infarct region and were
therefore graded as viable. In contrast, the presence of dia-
stolic wall thinning accurately predicted persisting akinesia or
dyskinesia after revascularization in 9 of 11 patients (negative
predictive accuracy of 82%). This was also reflected by a
significantly higher DWT of infarct regions with improved
SWT after revascularization compared with the DWT of
infarct regions that remained dysfunctional. On a segmental
basis, there were only 12 (9.6%) of 125 segments with diastolic
wall thinning that showed SWT after revascularization (i.e.,
negative predictive accuracy of 90.4%). This again indicates
that diastolic wall thinning in the setting of chronic coronary
artery disease is a reliable variable of irreversibly damaged scar
tissue. In contrast, 106 (48%) of 219 segments with preserved
DWT did not improve, suggesting that MRI-assessed pre-
served DWT in dysfunctional infarct regions is not sufficient to
predict LV functional improvement. There are several reasons
for the discrepancy between the prediction of viability by
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preserved DWT and the postrevascularization lack of SWT
improvement resulting in a low specificity of this morphologic
viability variable:
1. We cannot exclude the possibility that the observation
time of 4 to 6 months between revascularization and control of
recovery of regional LV function was insufficient to allow for
functional improvement in successfully revascularized infarct
regions without dobutamine-induced SWT but preserved
DWT. These infarct zones with a functional and morphologic
mismatch may represent the most jeopardized regions before
revascularization that are likely to exhibit very slow recovery of
myocardial function after adequate reperfusion. If this is the
case, additional metabolic imaging with fluorine-18 fluorode-
oxyglucose PET may be a helpful complementary tool for
predicting functional recovery in a subgroup of patients with
preserved DWT but without dobutamine-induced SWT.
2. The choice of a threshold value for mean segmental SWT
$2 mm, based on a spatial resolution of 1.3 mm of the MRI
machine, may have partly contributed to the discrepancy
between preserved DWT and the postrevascularization lack of
SWT improvement. Despite preserved DWT, there may be
only small and functionally isolated remnants of viable myo-
cardium in the epicardial layer of the myocardial wall, and
these regions may not be able to produce detectable SWT
($2 mm) during dobutamine stimulation or after revascular-
ization (5,25). Another explanation for the discrepancy be-
tween preserved DWT and lack of functional recovery could be
the inclusion of patients with acute MI and incomplete scar
formation. In these patients, normal DWT could be present
despite acute necrosis. However, to circumvent this problem,
only patients with healed MI .4 months old were included in
the present study.
Prediction of increased LVEF by number of dobutamine-
responsive segments. In the present patient group, it is diffi-
cult to ascribe changes in LVEF solely to the effect of adequate
reperfusion and functional improvement in a specific infarct
region, because almost half of the study group underwent
bypass grafting that included other myocardial territories,
which may have influenced the global LVEF. However, the
number of dobutamine-responsive segments, irrespective of
the underlying infarct size, yielded fair correlation with the
increase in LVEF after revascularization and may therefore
allow rough estimation of the potential increase in LVEF after
successful revascularization. Bax et al. (33) showed that in
patients with three or more segments graded as viable by
fluorine-18 fluorodeoxyglucose single-photon emission com-
puted tomography, a significant improvement in postrevascu-
larization LVEF occurred. In our patient group, a threshold
value of four segments seemed to be adequate, because all
patients with four or more dobutamine-responsive segments
had an improved LVEF.
Conclusions. Fast MRI techniques are ideally suited to
depict functional and morphologic variables of myocardial
viability in a period of time that is now comparable to the
examination time needed by dobutamine–stress echocardiog-
raphy. The quantitative assessment of dobutamine-induced
SWT in patients with chronic coronary artery disease and
dysfunctional myocardium is highly predictive of postrevascu-
larization functional recovery of the respective region, and the
number of segments with dobutamine-induced SWT provides a
rough estimate of the potential increase in LVEF after suc-
cessful revascularization. The depiction of significantly re-
duced DWT excludes a clinically relevant amount of persistent
viable myocardium. Therefore, an additional dobutamine
stress test does not improve the diagnostic yield in the presence
of significant diastolic wall thinning.
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